S
Socovesa SA
SGO:SOCOVESA
Socovesa SA
SGO:SOCOVESA
Price:
65.09
CLP
Market Closed
Market Cap:
79.7B
CLP
Add
Note
Why Create Notes?
Capture your thoughts
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
| US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Peter Lynch
Track and Analyze Performance
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Continuous Learning and Adaptation
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
Boost Decision Confidence
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Delete Note
Do you really want to delete this note?
This action cannot be undone.
SOCOVESA Alert
Socovesa SA
65.09
0.00 (0%)
| 52 Week Range |
54.88
101.15
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CLP.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
Abbvie Inc
NYSE:ABBV
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Realty Income Corp
NYSE:O
|
US |
|
|
Walt Disney Co
NYSE:DIS
|
US |
|
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Delete Alert
This alert will be permanently deleted.
Ask me anything about
Socovesa SA
Balance Sheet
Balance Sheet Decomposition
Socovesa SA
Socovesa SA
| Current Assets | 592.5B |
| Cash & Short-Term Investments | 5.7B |
| Receivables | 137.8B |
| Other Current Assets | 449B |
| Non-Current Assets | 608.7B |
| Long-Term Investments | 211.8B |
| PP&E | 13.9B |
| Intangibles | 89.1B |
| Other Non-Current Assets | 293.8B |
| Current Liabilities | 819B |
| Accounts Payable | 29.2B |
| Short-Term Debt | 684.8B |
| Other Current Liabilities | 104.9B |
| Non-Current Liabilities | 38B |
| Long-Term Debt | 3.2B |
| Other Non-Current Liabilities | 34.8B |
Balance Sheet
Socovesa SA
Socovesa SA
Currency: CLP
| Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
9 764
|
5 210
|
4 574
|
9 035
|
4 200
|
6 577
|
7 184
|
32 498
|
27 173
|
6 322
|
|
| Cash |
9 764
|
5 210
|
4 574
|
9 035
|
4 200
|
6 577
|
7 184
|
7 447
|
11 393
|
4 231
|
|
| Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
25 052
|
15 780
|
2 091
|
|
| Short-Term Investments |
18 487
|
17 382
|
9 043
|
6 019
|
6 201
|
14 521
|
60 886
|
946
|
2 013
|
1 628
|
|
| Total Receivables |
142 976
|
143 853
|
131 481
|
177 085
|
189 655
|
169 492
|
116 363
|
142 386
|
127 066
|
144 997
|
|
| Accounts Receivables |
87 404
|
69 802
|
68 287
|
105 681
|
100 911
|
109 879
|
61 965
|
79 790
|
51 127
|
67 864
|
|
| Other Receivables |
55 571
|
74 050
|
63 194
|
71 404
|
88 744
|
59 613
|
54 397
|
62 596
|
75 940
|
77 133
|
|
| Inventory |
276 239
|
293 211
|
322 011
|
242 881
|
268 666
|
289 519
|
270 873
|
268 643
|
392 609
|
473 106
|
|
| Other Current Assets |
1 173
|
1 189
|
1 645
|
1 759
|
4 565
|
1 514
|
928
|
1 002
|
1 245
|
1 227
|
|
| Total Current Assets |
448 639
|
460 844
|
468 754
|
436 780
|
473 287
|
481 623
|
456 234
|
445 476
|
550 106
|
627 280
|
|
| PP&E Net |
19 469
|
20 003
|
18 758
|
19 446
|
11 913
|
18 630
|
16 014
|
14 357
|
14 538
|
14 528
|
|
| PP&E Gross |
19 469
|
20 003
|
18 758
|
19 446
|
11 913
|
18 630
|
16 014
|
14 357
|
14 538
|
14 528
|
|
| Accumulated Depreciation |
12 283
|
12 838
|
13 156
|
13 780
|
12 579
|
14 280
|
15 380
|
18 639
|
21 438
|
20 700
|
|
| Intangible Assets |
53 657
|
55 182
|
58 574
|
62 844
|
60 832
|
61 612
|
65 901
|
71 189
|
75 666
|
77 210
|
|
| Goodwill |
12 900
|
12 900
|
12 900
|
12 900
|
12 900
|
12 900
|
12 900
|
12 900
|
11 253
|
11 253
|
|
| Note Receivable |
32 161
|
18 342
|
17 092
|
13 928
|
21 572
|
20 648
|
35 174
|
23 714
|
35 206
|
35 114
|
|
| Long-Term Investments |
146 796
|
161 078
|
159 412
|
176 534
|
209 826
|
232 443
|
199 866
|
147 491
|
198 335
|
219 562
|
|
| Other Long-Term Assets |
149 978
|
114 175
|
128 759
|
150 245
|
161 113
|
221 451
|
262 369
|
296 469
|
272 463
|
250 333
|
|
| Other Assets |
12 900
|
12 900
|
12 900
|
12 900
|
12 900
|
12 900
|
12 900
|
12 900
|
11 253
|
11 253
|
|
| Total Assets |
863 601
N/A
|
842 524
-2%
|
864 249
+3%
|
872 677
+1%
|
951 442
+9%
|
1 049 307
+10%
|
1 048 458
0%
|
1 011 597
-4%
|
1 157 567
+14%
|
1 235 279
+7%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
9 921
|
9 153
|
7 176
|
7 911
|
23 318
|
32 460
|
26 921
|
21 409
|
20 107
|
20 618
|
|
| Short-Term Debt |
16 887
|
12 272
|
9 962
|
4 299
|
21 414
|
11 507
|
14 189
|
7 609
|
604 583
|
717 979
|
|
| Current Portion of Long-Term Debt |
418 935
|
356 463
|
383 229
|
370 311
|
409 835
|
491 050
|
520 021
|
445 072
|
2 686
|
1 827
|
|
| Other Current Liabilities |
110 527
|
127 815
|
145 361
|
147 134
|
123 784
|
130 684
|
84 647
|
117 525
|
112 187
|
105 727
|
|
| Total Current Liabilities |
556 271
|
505 703
|
545 728
|
529 656
|
578 351
|
665 701
|
645 778
|
591 616
|
739 562
|
846 151
|
|
| Long-Term Debt |
23 970
|
36 400
|
2 076
|
0
|
0
|
5 404
|
3 638
|
2 247
|
1 790
|
3 517
|
|
| Deferred Income Tax |
10 806
|
10 339
|
10 341
|
10 082
|
10 284
|
9 726
|
10 022
|
9 597
|
9 607
|
9 302
|
|
| Minority Interest |
14 065
|
10 564
|
3 555
|
9 759
|
9 841
|
8 839
|
11 893
|
7 387
|
6 538
|
5 659
|
|
| Other Liabilities |
2 385
|
2 737
|
3 472
|
6 312
|
15 644
|
10 551
|
19 117
|
15 835
|
15 672
|
11 513
|
|
| Total Liabilities |
607 497
N/A
|
565 743
-7%
|
565 171
0%
|
555 808
-2%
|
614 121
+10%
|
700 221
+14%
|
690 449
-1%
|
626 682
-9%
|
773 169
+23%
|
876 143
+13%
|
|
| Equity | |||||||||||
| Common Stock |
127 689
|
127 689
|
127 689
|
127 689
|
127 689
|
127 689
|
127 689
|
127 689
|
127 689
|
127 689
|
|
| Retained Earnings |
78 818
|
99 495
|
121 791
|
139 583
|
160 036
|
171 801
|
180 724
|
207 629
|
207 112
|
181 851
|
|
| Additional Paid In Capital |
49 597
|
49 597
|
49 597
|
49 597
|
49 597
|
49 597
|
49 597
|
49 597
|
49 597
|
49 597
|
|
| Total Equity |
256 104
N/A
|
276 781
+8%
|
299 077
+8%
|
316 869
+6%
|
337 321
+6%
|
349 087
+3%
|
358 009
+3%
|
384 915
+8%
|
384 398
0%
|
359 136
-7%
|
|
| Total Liabilities & Equity |
863 601
N/A
|
842 524
-2%
|
864 249
+3%
|
872 677
+1%
|
951 442
+9%
|
1 049 307
+10%
|
1 048 458
0%
|
1 011 597
-4%
|
1 157 567
+14%
|
1 235 279
+7%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
1 224
|
1 224
|
1 224
|
1 224
|
1 224
|
1 224
|
1 224
|
1 224
|
1 224
|
1 224
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
